#NWSCONF2023
The immune system speaks.
We listen.
MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.
MeMed BV - Bacterial or Viral?
®
We developed a pioneering test to help physicians with the seemingly simple clinical dilemma - is it a bacterial or viral infection?
By providing host response information, we help physicians make more informed decisions about how and when to treat.
From a small serum sample, MeMed BV computationally integrates the level of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.
MeMed BV Performance
The study was conducted to establish the diagnostic performance of the MeMed BV test for differentiating bacterial from viral infection in patients with suspected acute bacterial or viral infection.
MeMed BV is uniquely both double-blind and externally validated.
MeMed BV performance goals independently confirmed in unprecedented validation and real-world usage encompassing >20,000 patients.
*Data on file. Based on secondary endpoint analysis in Apollo Clinical Study (NCT04690569).
1-7
Click to read the full articles here:
Conventional tests are often insufficient because...
Inaccessible infection sites
Often no pathogens are detected
False alarms due to colonization
Prolonged time to results
Uncertainty regarding severity
MeMed Key
MeMed Key runs the MeMed BV test in just 15 minutes, where and when it actually matters. MeMed Key is a cutting edge, compact immunoassay platform that is accurate and easy to use, making it possible to conduct highly sensitive, rapid, multiplexed protein measurements that previously could only be done on expensive central lab equipment.
The MeMed BV test and MeMed Key platform are FDA cleared.
®
About MeMed
At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.
Download our clinical study summaries
References:
1. Data on file. Apollo Clinical Study (NCT04690569) conducted to establish the diagnostic performance of the MeMed BV Test for differentiating bacterial from viral infection in patients with suspected acute bacterial or viral infection; 2. Oved, K. et al. PLoS One (2015) 3. van Houten, C. B. et al. OPPORTUNITY: Lancet Infect. Dis. (2016); 4. Srugo, I. et al. Pediatrics (2017); 5. Ashkenazi-Hoffnung, L. et al. EJC MID (2018); 6. Stein et al. DMID (2017); 7. Eden et al. JOI (2016)